EcoDrugPlus

Ensembl ID : ENSOMYG00000010762
Gene Symbol: -
Cross references: -
89 Possible Orthologues:

Ensembl ID : ENSOMYG00000010489
Gene Symbol: -
Cross references: -
182 Possible Orthologues:

Ensembl ID : ENSOMYG00000041340
Gene Symbol: -
Cross references: -
153 Possible Orthologues:

Ensembl ID : ENSOMYG00000011961
Gene Symbol: -
Cross references: -
198 Possible Orthologues:

Ensembl ID : ENSOMYG00000011995
Gene Symbol: -
Cross references: -
179 Possible Orthologues:

Ensembl ID : ENSOMYG00000011877
Gene Symbol: -
Cross references: -
187 Possible Orthologues:

Ensembl ID : ENSOMYG00000038030
Gene Symbol: -
Cross references: -
198 Possible Orthologues:

Ensembl ID : ENSOMYG00000013769
Gene Symbol: -
Cross references: -
192 Possible Orthologues:

Ensembl ID : ENSOMYG00000037470
Gene Symbol: -
Cross references: -
210 Possible Orthologues:

Ensembl ID : ENSOMYG00000013833
Gene Symbol: -
Cross references: -
197 Possible Orthologues:

Ensembl ID : ENSOMYG00000013988
Gene Symbol: -
Cross references: -
151 Possible Orthologues:

Ensembl ID : ENSOMYG00000014212
Gene Symbol: -
Cross references: -
199 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).